| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
20 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-12-22 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Signing the purchase agreement for CompuFlo Epidural / CathCheck Verification System
disposables with a premier northeast teaching hospital
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that following a successful trial, it has signed an agreement for
the purchase of the CompuFlo Epidural and CathCheck Verification System disposables
with a major northeast teaching hospital, which is part of one of the leading health
systems in the United States. The name of the hospital cannot be disclosed for confidentiality
reasons.
The Board of Directors of the Company is pleased to announce adoption of CompuFlo
Epidural and CathCheck Verification System by yet another major hospital. This approval
follows an extensive trial, which further validates the safety and efficacy of the
technology. As a teaching hospital, the CompuFlo Epidural and CathCheck Verification
Systems provide residents, fellows and even seasoned physicians greater accuracy through
real-time verification of epidural needle placement, as well as subsequent monitoring
of catheter placement.
While the initial rollout is focused on the labor and delivery market, The Board of
Directors of the Company is also targeting the pain management sector. The network
of this major northeast teaching hospital, not only includes numerous hospitals, but
also specialty centers, outpatient centers and sports medicine centers.
The CompuFlo Epidural Instrument has the potential to reduce costs associated with
morbidity, providing a direct economic benefit to healthcare institutions. Similarly,
the CathCheck Verification System technology has the potential to transform the monitoring
of catheter placement following an epidural procedure by confirming the placement
of a catheter within two minutes, versus the 20 to 40 minutes using conventional methods.
In the opinion of the Board of Directors of the Company, the clinical and safety benefits
of the CompuFlo Epidural and CathCheck Verification Systems are backed by extensive
published clinical data demonstrating reductions in epidural punctures, as well as
complication rates, and contribute to savings of time on the part of anesthesiologists.
|
|
|
RB_ASO: Signing the purchase agreement for CompuFlo Epidural / CathCheck Verification System
disposables with a premier northeast teaching hospital
